XML 48 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of significant components of the company's deferred tax asset
   

December 31,

   

December 31,

 
   

2022

   

2021

 
   

USD thousands

   

USD thousands

 

Net operating loss carry-forwards

   

36,550

     

33,396

 

Share-based compensation expense

   

1,774

     

1,147

 

Research and development costs

   

2,858

     

1,449

 

Other

   

13

     

38

 

Gross deferred tax assets

   

41,195

     

36,030

 

Less - Valuation allowance

   

(41,195

)

   

(36,030)

 

 

               

Net deferred tax assets

   

-

     

-

 
Schedule of roll forward of valuation allowance

Balance at January 1, 2021

 

$

6,200

 

Currency transaction loss

   

2,425

 

Tax assets acquired through merger

    24,535  

Income tax expense

   

2,870

 

Balance at December 31, 2021

 

$

36,030

 

Currency transaction Income

   

(1,316

)

Income tax expense

   

6,481

 

Balance at December 31, 2022

 

$

41,195

 
Schedule of reconciliation of theoretical income tax expense to actual income tax expense
   

December 31,

   

December 31,

 
   

2022

   

2021

 
   

USD thousands

   

USD thousands

 

Loss before income taxes

   

(28,180

)

   

(12,478

)

Statutory tax rate

   

23

%

   

23

%

Theoretical tax benefit

   

(6,481

)

   

(2,870

)

 

               

Change in temporary differences for which deferred taxes were not recognized

   

(1,696

)    

(1,332

)

Tax rate differential

   

20

     

(101

)

Non-deductible expenses

   

744

     

239

 

Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards

   

6,879

     

4,064

 

Actual income tax expense (Benefit)

   

(534

)

   

-